Satellos Bioscience Inc. Common Stock (MSLE) — Working Capital to Net Assets Ratio
Satellos Bioscience Inc. Common Stock (MSLE) has a Working Capital to Net Assets ratio of 100.0% as of June 2026. Working capital of $59.83 Million (current assets of $65.68 Million minus current liabilities of $5.85 Million) is measured against net assets of $59.84 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See defensive interval ratio of Satellos Bioscience Inc. Common Stock to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Satellos Bioscience Inc. Common Stock Working Capital to Net Assets (2007–2025)
This chart shows how Satellos Bioscience Inc. Common Stock's Working Capital to Net Assets ratio has evolved across 19 annual periods from 2007 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting working capital of $59.83 Million against net assets of $59.84 Million USD. For the complete balance sheet picture, see Satellos Bioscience Inc. Common Stock asset portfolio.
Annual Working Capital to Net Assets for Satellos Bioscience Inc. Common Stock (2007–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Satellos Bioscience Inc. Common Stock from 2007 to 2025, covering 19 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check MSLE financial resilience to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 100.0% | $27.78 Million | $27.78 Million | $31.88 Million | $4.11 Million | ▼ 0.0 pp |
| 2024 | 100.0% | $47.28 Million | $47.28 Million | $50.87 Million | $3.59 Million | ▲ +9.8 pp |
| 2023 | 90.2% | $36.70 Million | $40.67 Million | $40.32 Million | $3.62 Million | ▲ +107.9 pp |
| 2022 | -17.7% | $-591.04K | $3.34 Million | $2.21 Million | $2.80 Million | ▼ -49.6 pp |
| 2021 | 31.9% | $2.62 Million | $8.22 Million | $4.27 Million | $1.65 Million | ▲ +525.7 pp |
| 2020 | -493.8% | $909.84K | $-184.25K | $1.13 Million | $220.46K | ▼ -592.9 pp |
| 2019 | 99.1% | $672.42K | $678.67K | $1.50 Million | $829.64K | ▼ -1.4 pp |
| 2018 | 100.5% | $-625.67K | $-622.52K | $174.46K | $800.13K | ▲ +0.6 pp |
| 2017 | 99.9% | $1.10 Million | $1.10 Million | $1.39 Million | $292.51K | ▲ +1.1 pp |
| 2016 | 98.8% | $2.30 Million | $2.33 Million | $2.44 Million | $139.24K | ▲ +1.2 pp |
| 2015 | 97.6% | $3.68 Million | $3.77 Million | $3.79 Million | $114.92K | ▲ +21.3 pp |
| 2014 | 76.3% | $4.01 Million | $5.26 Million | $5.52 Million | $1.51 Million | ▲ +119.5 pp |
| 2013 | -43.2% | $-533.11K | $1.23 Million | $1.96 Million | $2.50 Million | ▼ -60.4 pp |
| 2012 | 17.2% | $353.33K | $2.05 Million | $1.32 Million | $965.94K | ▼ -25.3 pp |
| 2011 | 42.5% | $1.14 Million | $2.69 Million | $1.40 Million | $254.62K | ▼ -33.9 pp |
| 2010 | 76.4% | $1.83 Million | $2.40 Million | $2.13 Million | $293.31K | ▼ -8.0 pp |
| 2009 | 84.3% | $3.63 Million | $4.31 Million | $3.96 Million | $323.03K | ▲ +61.4 pp |
| 2008 | 22.9% | $204.84K | $894.78K | $592.13K | $387.29K | ▼ -41.6 pp |
| 2007 | 64.5% | $1.60 Million | $2.49 Million | $2.38 Million | $780.80K | — |